Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]

Combination therapy with idelalisib better prevents disease progression in...

Dr Andrew D. Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA

Combination therapy with idelalisib better prevents disease progression in relapsed or treatment-resistant chronic lymphocytic leukaemia than current regimen ( Dr Andrew D. Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA )

Study underscores promise of targeted therapies as first-line approach for...

Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano...

Study underscores promise of targeted therapies as first-line approach for patients with chronic lymphocytic leukaemia ( Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy )

First targeted therapy for multiple myeloma effective against hard-to-treat...

Dr Torben Plesner - Vejle Hospital, University of Southern Denmark, Vejle...

First targeted therapy for multiple myeloma effective against hard-to-treat disease ( Dr Torben Plesner - Vejle Hospital, University of Southern Denmark, Vejle, Denmark )

First targeted therapy for genetically defined subset of patients with acute...

Dr Richard M. Stone - Dana-Farber Cancer Institute, Boston, USA

First targeted therapy for genetically defined subset of patients with acute myeloid leukaemia significantly improves survival ( Dr Richard M. Stone - Dana-Farber Cancer Institute, Boston, USA )

Exciting evidence for first all-oral treatment for relapsed and treatment...

Prof Philippe Moreau - University of Nantes, Nantes, France

Exciting evidence for first all-oral treatment for relapsed and treatment-resistant multiple myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )

Study finds new use for rituximab in acute lymphoblastic leukaemia

Prof Sébastien Maury - Hôpital Henri Mondor, Créteil, France

Study finds new use for rituximab in acute lymphoblastic leukaemia ( Prof Sébastien Maury - Hôpital Henri Mondor, Créteil, France )

First targeted therapy for multiple myeloma effective against hard-to-treat...

Dr Torben Plesner - Vejle Hospital, Vejle, Denmark

First targeted therapy for multiple myeloma effective against hard-to-treat disease ( Dr Torben Plesner - Vejle Hospital, Vejle, Denmark )

First targeted therapy for genetically defined subset with acute myeloid...

Dr Richard Stone - Dana Farber Cancer Institute, Boston, USA

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival ( Dr Richard Stone - Dana Farber Cancer Institute, Boston, USA )

Variants for increased risk of osteonecrosis in paediatric acute lymphocytic...

Dr Seth Karol - St Jude Children's Research Hospital, Tampa, USA

Variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified ( Dr Seth Karol - St Jude Children's Research Hospital, Tampa, USA )

Immunotherapy makes patients’ tumours "melt away"

Dr Joshua Brody - Mount Sinai Medical Center, New York, USA

Immunotherapy makes patients’ tumours "melt away" ( Dr Joshua Brody - Mount Sinai Medical Center, New York, USA )

Quality assessment looking at rivaroxaban for cancer-related thrombosis

Dr Gerald Soff - Memorial Sloan Kettering Cancer Center, New York, USA

Quality assessment looking at rivaroxaban for cancer-related thrombosis ( Dr Gerald Soff - Memorial Sloan Kettering Cancer Center, New York, USA )

Guidance for anticoagulation management in the setting of thrombocytopenia in...

Dr Gerald Soff - Memorial Sloan Kettering Cancer Center, New York, USA

Guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients ( Dr Gerald Soff - Memorial Sloan Kettering Cancer Center, New York, USA )

More from ecancer